Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies

Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies have?

Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies has 15 citations in the OpenAlex counts ScholarIQ stores.

When was Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies published?

Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies has 1998 year in the ScholarIQ index.

What is the open-access status of Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies?

Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies has closed oa status in the ScholarIQ index.

What is the DOI of Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies?

The DOI for Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies is on the source record.

What is the PMID of Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies?

The PMID for Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies is on the source record.

What is the OpenAlex record for Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies?

The OpenAlex for Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies is on the source record.